Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.

AS1404

MedGen UID:
321816
Concept ID:
C1831616
Pharmacologic Substance
2.

5,6-dimethylxanthenoneacetic acid, sodium salt

MedGen UID:
189662
Concept ID:
C0958452
Pharmacologic Substance
3.

Error occurred: cannot get document summary

ID:
89200

4.

Error occurred: cannot get document summary

ID:
42663

5.

human papillomavirus vaccine, TA

A vaccinia viral based vaccine, encoding epitopes of E6 and E7 proteins from human papillomavirus (HPV) types 16 and 18, with immunostimulatory and antineoplastic activities. HPV types 16 and 18 account for approximately 70% of cervical cancers. Vaccination with this HPV-TA (tumor antigen) vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for E6 and E7 from either type 16 or 18 HPV, resulting in decreased tumor growth. [from NCI]

MedGen UID:
97749
Concept ID:
C0390856
Pharmacologic Substance
6.

vadimezan

A fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages. [from NCI]

MedGen UID:
418851
Concept ID:
C2930490
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...